Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1957 1
1958 1
1960 2
1962 1
1963 2
1964 4
1965 6
1966 3
1967 4
1968 11
1969 2
1970 11
1971 12
1972 8
1973 3
1974 4
1975 6
1976 2
1977 3
1978 6
1979 2
1980 3
1981 10
1982 8
1983 8
1984 8
1985 6
1986 4
1987 6
1988 8
1989 5
1990 8
1991 2
1992 9
1993 7
1994 4
1995 10
1996 9
1997 8
1998 11
1999 14
2000 16
2001 13
2002 14
2003 19
2004 14
2005 33
2006 38
2007 48
2008 49
2009 44
2010 43
2011 40
2012 44
2013 41
2014 54
2015 45
2016 41
2017 31
2018 46
2019 40
2020 49
2021 57
2022 58
Text availability
Article attribute
Article type
Publication date

Search Results

1,015 results
Results by year
Filters applied: . Clear all
Page 1
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U; VIEW 1 and VIEW 2 Study Groups. Heier JS, et al. Among authors: kaiser pk. Ophthalmology. 2012 Dec;119(12):2537-48. doi: 10.1016/j.ophtha.2012.09.006. Epub 2012 Oct 17. Ophthalmology. 2012. PMID: 23084240 Clinical Trial.
Intravitreal aflibercept for diabetic macular edema.
Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM. Korobelnik JF, et al. Among authors: kaiser pk. Ophthalmology. 2014 Nov;121(11):2247-54. doi: 10.1016/j.ophtha.2014.05.006. Epub 2014 Jul 8. Ophthalmology. 2014. PMID: 25012934 Clinical Trial.
Brolucizumab-early real-world experience: BREW study.
Sharma A, Kumar N, Parachuri N, Sadda SR, Corradetti G, Heier J, Chin AT, Boyer D, Dayani P, Arepalli S, Kaiser P. Sharma A, et al. Among authors: kaiser p. Eye (Lond). 2021 Apr;35(4):1045-1047. doi: 10.1038/s41433-020-1111-x. Epub 2020 Jul 24. Eye (Lond). 2021. PMID: 32709960 Free PMC article. No abstract available.
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, Becker M, Junker D, Krause G, Strengert M, Schneiderhan-Marra N, Templin MF, Joos TO, Kowalewski DJ, Stos-Zweifel V, Fehr M, Rabsteyn A, Mirakaj V, Karbach J, Jäger E, Graf M, Gruber LC, Rachfalski D, Preuß B, Hagelstein I, Märklin M, Bakchoul T, Gouttefangeas C, Kohlbacher O, Klein R, Stevanović S, Rammensee HG, Walz JS. Nelde A, et al. Among authors: kaiser pd. Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30. Nat Immunol. 2021. PMID: 32999467
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG, Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS. Monés J, et al. Among authors: kaiser pk. Ophthalmology. 2021 Jul;128(7):1050-1059. doi: 10.1016/j.ophtha.2020.11.011. Epub 2020 Nov 15. Ophthalmology. 2021. PMID: 33207259 Free article. Clinical Trial.
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Heier JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, Do DV, Midena E, Boyer DS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Vitti R, Berliner AJ, Zeitz O, Metzig C, Holz FG. Heier JS, et al. Among authors: kaiser pk. Ophthalmology. 2016 Nov;123(11):2376-2385. doi: 10.1016/j.ophtha.2016.07.032. Epub 2016 Sep 17. Ophthalmology. 2016. PMID: 27651226 Clinical Trial.
[Primary soft tissue management in open fracture].
Riechelmann F, Kaiser P, Arora R. Riechelmann F, et al. Among authors: kaiser p. Oper Orthop Traumatol. 2018 Oct;30(5):294-308. doi: 10.1007/s00064-018-0562-8. Epub 2018 Sep 4. Oper Orthop Traumatol. 2018. PMID: 30182178 Review. German.
Port delivery system: a novel drug delivery platform to treat retinal diseases.
Khanani AM, Aziz AA, Weng CY, Lin WV, Vannavong J, Chhablani J, Danzig CJ, Kaiser PK. Khanani AM, et al. Among authors: kaiser pk. Expert Opin Drug Deliv. 2021 Nov;18(11):1571-1576. doi: 10.1080/17425247.2021.1968826. Epub 2021 Aug 24. Expert Opin Drug Deliv. 2021. PMID: 34388956 Review.
1,015 results